TheraRadar
Clinical-Stage Companies / medac

medac

Pre-Approval PRO BETA
🔴

Stale Activity

No new clinical trials started in 2+ years. Activity may be declining or company may be focusing on existing programs. Last trial started: 2/27/2024

15
Total Trials
6
Phase 3
6
Phase 2
4
Recruiting
150
Score

Pipeline by Phase

Phase 3
6
Phase 2
6
Phase 1
4

Therapeutic Focus

Steroid-refractory Acute Graft-versus-host Disease Acute B-Cell Lymphoblastic Leukaemia Primary Immunodeficiencies Inborn Errors of Metabolism Haemoglobinopathies

Clinical Trials (15)

NCT06239311 Phase 3 RECRUITING

Efficacy and Safety of Methotrexate Versus Placebo in Adults With Atopic Dermatitis.

Started: 2/27/2024

NCT04629833 Phase 3 RECRUITING

Treatment Of Steroid-Refractory Acute Graft-versus-host Disease With Mesenchymal Stromal Cells Versus Best Available Therapy

Started: 8/16/2021

NCT00822393 Phase 3 COMPLETED

Clinical Phase III Trial Treosulfan-based Conditioning Versus Reduced-intensity Conditioning (RIC)

Started: 11/24/2008

NCT00823225 Phase 3 TERMINATED

Urokinase Therapy in Patients With Diabetic Foot Syndrome

Started: 6/1/2008

NCT01793259 Phase 3 COMPLETED

Preference Methotrexate (MTX) Pre-filled Syringe Versus Pre-filled Pen in Rheumatoid Arthritis (RA)

Started: 7/1/2012

NCT00784017 Phase 3 COMPLETED

Comparative Efficacy and Safety of Two Asparaginase Preparations in Children With Previously Untreated Acute Lymphoblastic Leukaemia

Started: 10/1/2008

NCT06075706 Phase 2 ACTIVE NOT RECRUITING

Trial of Efficacy and Safety of MC0518 Versus Best Available Therapy in Participants With Steroid-Refractory Acute Graft Versus Host Disease

Started: 11/13/2023

NCT03156790 Phase 2 TERMINATED

PK, PD, Safety and Immunogenicity of Spectrila in Adults With Acute B-cell Lymphoblastic Leukaemia

Started: 4/26/2019

NCT02349906 Phase 2 COMPLETED

Treosulfan-based Versus Busulfan-based Conditioning in Paediatric Patients With Non-malignant Diseases

Started: 4/1/2015

NCT02333058 Phase 2 COMPLETED

Treosulfan-based Conditioning in Paediatric Patients With Haematological Malignancies

Started: 11/21/2014

NCT00983138 Phase 2 COMPLETED

Efficacy and Safety of Recombinant Asparaginase in Infants With Previously Untreated Acute Lymphoid Leukemia (ALL)

Started: 7/1/2009

NCT05534620 Phase 1 RECRUITING

Effect of Moderate Renal Impairment and Race/Ethnicity on Treosulfan Pharmacokinetics

Started: 2/1/2024

NCT02097173 Phase 1 COMPLETED

Bioavailability in Patient With Psoriasis: Metoject Prefilled Pen

Started: 5/1/2013

NCT01871961 Phase 1 COMPLETED

Evaluation of Patient Performance Using the Metoject Device for Subcutaneous Injection in Rheumatoid Arthritis (RA)Patient

Started: 10/1/2012

NCT01251809 Phase 1 TERMINATED

Trial of Oncaspar® and Three Doses of Pegylated Recombinant Asparaginase in Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukaemia

Started: 1/1/2011

Drug Candidates

MC0518 BAT Spectrila® Treosulfan Busilvex Fludarabine Methotrexate Placebo Busulfan Methotrexate (Metoject® prefilled pen)
Activity Status: Stale
Last Trial Started: 2/27/2024
Last Trial Ended: 12/19/2025
Trials (12 months): 0
Completed Trials: 8
Data sourced from ClinicalTrials.gov. This company has no FDA-approved drugs.